Parameters | Failure | Sub-Optimal | Optimal |
---|---|---|---|
Number (%) | Number (%) | Number (%) | |
Whole population | |||
Outcome | 167 (12.39) | 113 (8.38) | 1068 (79.23) |
Age | |||
<60 years | 80 (10.15) | 57 (7.23) | 651 (82.61) |
≥60 years | 87 (15.54) | 56 (10.00) | 417 (74.46) |
Lenalidomide use | |||
No | 113 (11.39) | 78 (7.86) | 801 (80.75) |
Yes | 54 (15.17) | 35 (9.83) | 267 (75.00) |
Hematological toxicity | |||
No | 132 (10.48) | 106 (8.41) | 1022 (81.11) |
Yes | 35 (39.77) | 7 (7.95) | 46 (52.27) |
Baseline cytopenia | |||
No | 117 (11.52) | 80 (7.87) | 819 (80.61) |
Yes | 50 (15.06) | 33 (9.94) | 249 (75.00) |